Adverse Events Monitoring, Pharmacovigilance, Risk Management, and Recalls

Adverse Events Monitoring, Pharmacovigilance and Risk Management - March 2015
by Katharine R. Latimer, Partner at Hollingsworth LLP (Washington, DC), Linda Pissott Reig, Shareholder at Buchanan Ingersoll & Rooney PC

Part of

Session: Adverse Events Monitoring, Pharmacovigilance, Risk Management, and Recalls

Part of Conference:

March 10 – 11, 2015

New York, NY

Purchase Products